Cullen/Frost Bankers, Inc.
BankPosition in AUPH — Aurinia Pharmaceuticals Inc.
CIK 39263
San Antonio, TX
Position in AUPH
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$28,933
New position
Shares Held
1,705
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#223
of 279 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cullen/Frost Bankers, Inc. holds $19,437,519 across 25 Biotechnology names. AUPH ranks #9 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
18,291 | $9,085,688 | |
| 2 | INSM |
INSMED Inc
|
54,740 | $5,836,378 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
10,977 | $3,304,406 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,028 | $640,999 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
3,868 | $136,888 | |
| 6 | EXEL |
Exelixis, Inc.
|
2,148 | $116,872 | |
| 7 | RPRX |
Royalty Pharma plc
|
2,016 | $113,037 | |
| 8 | ARGX |
Argenx SE
|
74 | $68,654 |
All Filings in AUPH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,933 | 1,705 | Shares | Defined | 2026-07-27 | |
| No filing history on record for this holder in this stock. | ||||||